Curanex Pharmaceuticals
$4.46
9
+$0.00+0%Friday 00:35
Statistics
Day High
4.46
Day Low
4.46
52W High
5.54
52W Low
0.1995
Volume
-
Avg. Volume
-
Mkt Cap
6.99M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Unprofitable0Revenue
-4.23MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
Show More
CEO
ISIN
US23126K1060
Listings
0 Comments
Share your thoughts
FAQs
What is Curanex Pharmaceuticals stock price today?▼
The current price of CURX.BOATS is $4.46 USD — it has increased by +0% in the past 24 hours. Watch Curanex Pharmaceuticals stock price performance more closely on the chart.
What is Curanex Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Curanex Pharmaceuticals stocks are traded under the ticker CURX.BOATS.
What is Curanex Pharmaceuticals market cap?▼
Today Curanex Pharmaceuticals has the market capitalization of 6.99M
What is Curanex Pharmaceuticals revenue for the last year?▼
Curanex Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Curanex Pharmaceuticals net income for the last year?▼
CURX.BOATS net income for the last year is -4.23M USD.
In which sector is Curanex Pharmaceuticals located?▼
Curanex Pharmaceuticals operates in the Other sector.
When did Curanex Pharmaceuticals complete a stock split?▼
The last stock split for Curanex Pharmaceuticals was on August 20, 2026 with a ratio of 1:20.